Logotype for Sudarshan Chemical Industries Limited

Sudarshan Chemical Industries (506655) Q3 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sudarshan Chemical Industries Limited

Q3 25/26 earnings summary

9 Sep, 2026

Executive summary

  • Consolidated Q3 FY26 results reflect continued market softness, with both legacy and acquired businesses experiencing lower revenues and profitability compared to the previous quarter and year-over-year.

  • Unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December 2025 were approved, reflecting the impact of a major acquisition and regulatory changes.

  • The group completed the acquisition of Heubach Group's global pigment business in March 2025, significantly expanding its international footprint.

  • Integration of acquired group progressing, with SAP system harmonization and cost-saving initiatives underway.

  • Customer destocking and high inventory levels persist, but early signs of demand recovery are visible in January and February.

Financial highlights

  • Q3 FY26 consolidated revenue from operations was ₹2,103 Cr, down from ₹2,387 Cr in Q2 FY26, but up from ₹666.4 Cr in Q3 FY25 due to the Heubach acquisition.

  • Adjusted EBITDA for Q3 FY26 was ₹40 Cr (1.9% margin), compared to ₹116 Cr (4.9% margin) in Q2 FY26; consolidated EBITDA was ₹37.9 Cr for Q3 FY26.

  • Q3 FY26 PBT before exceptional items was ₹30 Cr, with reported PBT at -₹77 Cr due to a ₹46 Cr impact from the new labour code.

  • Consolidated net loss for Q3 FY26 was ₹116 Cr, compared to a profit of ₹0.5 Cr in Q3 FY25; nine-month consolidated net loss was ₹41.7 Cr.

  • Exceptional items included a statutory impact of new Labour Codes and acquisition-related costs.

Outlook and guidance

  • Management expects the worst of the downturn is over, with customer trust returning and destocking easing.

  • Revised FY26 business EBITDA outlook for the acquired group is ~€16 Mn, down from earlier €25 Mn guidance.

  • Q4 FY26 expected to see positive sales momentum and ongoing value capture, but reported EBITDA may be temporarily lower due to inventory reduction.

  • Financial results for the period include the impact of the Heubach acquisition and are not comparable with previous periods.

  • The group continues to monitor regulatory developments and expects further adjustments as final rules on labour codes are clarified.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more